3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Myelodysplastic Syndromes
8
Advanced Solid Tumors
8
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Neoplasms
4
Multiple Myeloma
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumour
4
Advanced Solid Tumor
4
Small Cell Lung Carcinoma
3
Recurrence
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Leukemia, Monocytic, Acute
3
Triple Negative Breast Neoplasms
2
Thrombocythemia, Essential
2
Squamous Cell Carcinoma of Head and Neck
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Neoplasm Metastasis
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Malignant Solid Tumor
2
Advanced Lung Cancer
2
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Sunitinib
2
Everolimus
2
sargramostim
1
montanide ISA 51
1
lutetium Lu 177 dotatate
1
lanreotide
1
incomplete Freund's adjuvant
1
fludarabine phosphate
1
cabozantinib
1
belzutifan
1
X-Rays
1
Temozolomide
1
Phantoms, Imaging
1
Octreotide
1
Methods
1
Interleukin-13
1
Fluorodeoxyglucose F18
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Blood Specimen Collection
1
Biopsy
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenoma, Islet Cell
×
Injections
×
90 days
×
Clear all
No trials found.